Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
MARK2 pseudogene 4 (MARK2P4) is classified as a **pseudogene** related to the functional gene Microtubule Affinity Regulating Kinase 2 (MARK2), which encodes a serine/threonine protein kinase involved in cell polarity, microtubule regulation, and phosphorylation of microtubule-associated proteins[1]. However, pseudogenes such as MARK2P4 do **not code for functional proteins**, and there is no evidence in scientific databases or literature to suggest that MARK2P4 is a **drug target**, codes any functional product, or is implicated in disease mechanisms or drug response. The correct MARK2 gene is protein-coding and is associated with various cellular functions and diseases, but there is no indication that the pseudogene MARK2P4 has any such biological or therapeutic relevance[1][5]. Additionally, no major repositories document interacting drugs, biomarker status, or safety concerns related to MARK2P4. **Note:** - There appears to be potential confusion between MARK2 (the functional kinase) and the pseudogene MARK2P4; the literature and gene databases do not support MARK2P4 as a valid molecular drug target or a gene with known biological function. - MARK2P4 should not be used interchangeably with MARK2, and there is no evidence that it functions as a receptor, enzyme, transporter, or therapeutic target. If you require information about the functional kinase **MARK2** (Microtubule Affinity Regulating Kinase 2)—which *is* a serine/threonine-protein kinase implicated in cell polarity and microtubule dynamics[1]—please specify, as the gene and pseudogene are functionally distinct.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on MARK2 pseudogene 4 (MARK2P4).